Welcome to The Briefing: Register or log in to tailor our content to your needs

The Briefing is all about showing you what you're most interested in. Personalize the content on The Briefing by choosing exactly what you want to see.

Subject Relevance


Medical Imaging Agents

1 - 10 of 97 items

Scientists Develop Novel Technique for Kidney Research

One in four patients treated with the widely used anti-cancer drug cisplatin develop chronic kidney disease. To better understand how the treatment leads to kidney damage, and possibly prevent it, a team of researchers at Yale School of Medicine developed… Read more →

Real-time imaging of lung lesions during surgery helps localize tumors and improve precision

More than 80,000 people undergo resection of a pulmonary tumor each year, and currently the only method to determine if the tumor is malignant is histologic analysis. A new study reports that a targeted molecular contrast agent can be used… Read more →

Three new chemically activated fluorescent compounds to study biological systems

Fluorescent proteins, including the famous and commonly used green fluorescent protein (GFP), require an external light beam to strike the molecule for it to fluoresce. In the past, scientists have tried using luminescent proteins that are activated by other means,… Read more →

GSU scientists design new MRI technique for early detection of liver tumors

Scientists at Georgia State University (GSU) with funding from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have designed an imaging technique to detect early-stage liver tumors, and have proven it successful in mice. Their study in an animal… Read more →

Protein-Based MRI Contrast Agent Enhances Liver Cancer Detection


Liver cancer is the sixth most common cancer in the world, with close to 800,000 patients worldwide diagnosed with the disease annually. Current methods of diagnosis include blood tests, ultrasound imaging, CT scans, and MRI scans. MRI offers a highly detailed… Read more →

Study: Using isosmolar contrast agent during angioplasty reduces risk of renal and cardiac events

Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium (IOCM) agent Visipaque™ (iodixanol) than those using low-osmolar contrast media (LOCM), demonstrate data from abstracts presented at the EuroPCR Congress 2015 in Paris.

The abstracts… Read more →


Silver nanoclusters inside synthetic DNA have utility in bioimaging

A team of researchers at the University of Calfornia, Santa Barbara (UCSB) has created nanoscale silver clusters with unique fluorescence properties important for bioimaging.

The researchers positioned silver clusters at programmed sites on a nanoscale breadboard, a construction base for… Read more →

Novel Ga-68-PSMA-ligand PET/CT effective for early detection of prostate cancer recurrence

A recent study reported in The Journal of Nuclear Medicine compared use of the novel Ga-68-PSMA-ligand PET/CT with other imaging methods and found that it had substantially higher detection rates of prostate-specific membrane antigen (PSMA) in patients with biochemical recurrence… Read more →

Philips launches innovative 3D navigation system to enhance minimally invasive treatment of vascular disease

Royal Philips (NYSE: PHG, AEX: PHIA) has announced the launch of VesselNavigator*, its latest innovation in live 3D catheter navigation to guide the minimally invasive treatment of patients with vascular diseases such as aortic aneurysms (ballooning of the aorta). This… Read more →

Scientists visualize potential brain cancer treatments in real time with nanotechnology

Virginia Tech Carilion Research Institute scientists have developed new imaging techniques to watch dangerous brain tumor cells respond to treatment in real time.

Published in Nano Letters, the study was led by Zhi Sheng and Deborah Kelly, both assistant professors… Read more →

Cookies on IBME website

Our website uses cookies to provide us with important information about visitors. By continuing to browse the site we'll assume that you are happy to receive all cookies set by IBME.